C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor

Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
12/2006
12/26/2006	US7153827 Produced by recombinant techniques; stimulating angiogenesis for wound healing and for vascular tissue repair
12/26/2006	US7153823 Methods of use of fibroblast growth factor, vascular endothelial growth factor and related proteins in the treatment of acute and chronic heart disease
12/26/2006	US7153818 Amylolytic enzyme extracted from bacillus sp. A 7-7 (DSM 12368) and washing and cleaning agents containing this novel amylolytic enzyme
12/26/2006	US7153685 Mutant estrogen receptors and mutant estrogen response element; wide variety of applications, including gene therapy, in vivo and in vitro expression
12/26/2006	US7153684 Giving rise to embryoid bodies and multiple differentiated cell phenotypes in monolayer culture; can be maintained on feeder layers for at least 20 passages; nonmouse mammalian
12/26/2006	US7153683 Present invention relates generally to compositions and methods for modulating activity of MAP/ERK kinase MEK3 and/or other MEK family members; is particularly related to polypeptide variants of TAO proteins
12/26/2006	US7153680 Recombinant watermelon (Citrullus lanatus) hydroperoxide lyase and uses thereof
12/26/2006	US7153678 Polynucleotides encoding the novel human phosphatase, RET31, and variants thereof
12/26/2006	US7153677 Isolated, recombinantly produced, enzymatically active hyaluronan synthase; a single protein that is a dual-action catalyst that utilizes UDP-GlcA and UDP-GlcNAc to synthesize hyaluronic acid
12/26/2006	US7153676 purified protein; nucleic acid sequences encoding the transacylases and fragments of the transacylases can be cloned, using standard molecular biology techniques, into vectors to transform host cells
12/26/2006	US7153674 Comprises sucrose fructosyltransferases (SST) for fermenting water-soluble, biodegradable polysaccharides for use as detergents, suspension agents, artificial sweeteners and food additives
12/26/2006	US7153673 Channel, reservoirs configuration; polymerase chain reactions; heating channels using electricity
12/26/2006	US7153672 Preparing a cDNA molecule by contacting an RNA molecule, in the presence of dNTPs, with a non-LTR retrotransposon protein or polypeptide having reverse transcriptase, producing a cDNA molecule complementary to the RNA molecule
12/26/2006	US7153671 Method for relative quantification of methylation of cytosine bases in DNA samples
12/26/2006	US7153670 Isolated nucleic acid molecule of nucleotides that encode full-length WF-HABP, Hyaluronan-binding protein family
12/26/2006	US7153669 Nucleotide sequences coding protein for use in the diagnosis, treatment and prevention of autoimmune, cell proliferative and inflammatory diseases
12/26/2006	US7153668 Nucleotide sequences coding polypeptide for use in the treatment of cardiovascular disoders
12/26/2006	US7153667 Discrete acyltransferases associated with type I polyketide synthases and methods of use
12/26/2006	US7153665 Using retroviral expression vector comprising immunoglobulin E and regulatory sequences to transfom cells and identify regulator of immunoglobulin E biosynthesis
12/26/2006	US7153664 Nucleotide sequences coding polypeptide for use in the treatment of inflammatory disorders
12/26/2006	US7153661 Artificial antibody polypeptides
12/26/2006	US7153655 Method for in vitro molecular evolution of protein function involving the use of exonuclease enzyme and two populations of parent polynucleotide sequence
12/26/2006	US7153653 Regulation of gene expression; determining DNA methylation and relation to cell proliferative disorder
12/26/2006	US7153652 Mismatch repair detection
12/26/2006	US7153525 forming oil in water emulsions containing drugs by heating nanostructure particle size matrices, surfactants and drugs, then cooling while stirring
12/26/2006	US7153512 Bovine immunodeficiency virus (BIV) based vectors
12/26/2006	US7153511 Avian herpesvirus-based recombinant Infectious Bursal Disease vaccine
12/26/2006	US7153510 Recombinant vesiculoviruses and their uses
12/26/2006	US7153507 A human monoclonal antibody specifically binds to human IL-15 and to inhibit IL-15-induced proinflammatory effects; tumor necrosis factor; antiinflammatory, -arthritic, -carcinogenic, proliferative agents; rheumatic diseases; transplants
12/26/2006	US7153501 Hematopoietic stem cells and methods of treatment of neovascular eye diseases therewith
12/26/2006	US7153499 Promoting differentiation and maturation of immature dendritic cells in a regional lymph node (especially by administering a natural cytokine mixture parilymphatically) so that the cells deliver T-cell antigen to effect immunization
12/26/2006	US7153433 Membrane's binding properties with respect to nucleic acids being adjustable by controlling the conditions in an ambient medium, characterized in that membrane is functionalized with deportonable groups
12/21/2006	WO2006135786A2 Methods for synthesis of encoded libraries
12/21/2006	WO2006135762A1 Identification of a folliculin-binding protein fnip1
12/21/2006	WO2006135717A1 Sclerotinia-resistant brassica and methods for development of resistance to sclerotinia
12/21/2006	WO2006135702A2 Methods of using redox-active surfactants to control polymer interactions
12/21/2006	WO2006135434A2 Semi-soft c-class immunostimulatory oligonucleotides
12/21/2006	WO2006135431A2 Inhibition of metallo-beta-lactamase by rna
12/21/2006	WO2006135413A2 Encapsidation system for production of recombinant virus-like particles
12/21/2006	WO2006135385A2 Antagonizing interleukin-21 receptor activity
12/21/2006	WO2006135342A1 Method of processing and/or genome mapping of ditag sequences
12/21/2006	WO2006135263A1 Fibroblast growth factor receptor-5 antibodies and methods for their use
12/21/2006	WO2006135110A1 Sulfate ion transporter gene and use thereof
12/21/2006	WO2006135096A1 Method of site specifically introducing tyrosine analogue into protein
12/21/2006	WO2006135069A1 Osteoclast differentiation/formation inhibitor, and screening method for prophylactic or therapeutic agent for metabolic bone disorder
12/21/2006	WO2006135045A1 Biochip substrate and biochip
12/21/2006	WO2006135027A1 Agent for treatment of wound and/or promotion of wound healing
12/21/2006	WO2006134960A1 Screening method for anti-inflammatory agent
12/21/2006	WO2006134917A1 Method for production of antibody
12/21/2006	WO2006134903A1 Method of constructing crop having large-sized flower and/or fruit
12/21/2006	WO2006134871A1 Method for transfer of gene into fat cell or progenitor fat cell
12/21/2006	WO2006134496A2 Homeologous recombination in msh2 inactivated plants or cells thereof
12/21/2006	WO2006134443A1 Dengue serotype 2 attenuated strain
12/21/2006	WO2006134342A2 Mutants of human app and their use for the production of transgenic animals
12/21/2006	WO2006134281A1 Shuttle vector and use thereof in assessing mutation phenomenon
12/21/2006	WO2006134240A1 Method for selecting stable proteins in non-standard physicochemical conditions
12/21/2006	WO2006134203A1 Compounds for treating or preventing amine oxidase related diseases or disorders
12/21/2006	WO2006134162A2 Lecitin-like protein kinase stress-related polypeptides and methods of use in plants
12/21/2006	WO2006134125A1 Antigen conjugates and uses thereof
12/21/2006	WO2006133983A1 Starchy-endosperm and/or germinating embryo-specific expression in mono-cotyledonous plants
12/21/2006	WO2006133970A2 Novel plants
12/21/2006	WO2006133931A2 Identification of jak/stat pathway modulating genes by genome wide rnai screening
12/21/2006	WO2006133911A2 Hepatitis c virus nucleic acid vaccine
12/21/2006	WO2006133758A2 Device for enriching/separating dna containing unmethylated cpg motives
12/21/2006	WO2006133566A1 NOVEL Aß-BINDING PROTEIN AND ITS PEPTIDE DERIVATIVES AND USES THEREOF
12/21/2006	WO2006133561A1 Method of cancer treatment using sirna silencing
12/21/2006	WO2006133560A1 Psp94 diagnostic reagents and assays
12/21/2006	WO2006133508A1 Methods of treatment, and diagnosis of epilepsy by detecting mutations in the scn1a gene
12/21/2006	WO2006133488A1 Cell specific, inducible or repressible, expression system
12/21/2006	WO2006119096A3 Infectious particle composition and methods of use thereof
12/21/2006	WO2006110182A3 Orthogonal translation components for the in vivo incorporation of unnatural amino acids
12/21/2006	WO2006109045A3 Cathepsin s antibody
12/21/2006	WO2006108718B1 Micro rna
12/21/2006	WO2006108474A3 Use of a galectin-1-trageted rnai-based approach for the treatment of cancer
12/21/2006	WO2006103094A3 Method for treating a sample that contains biomolecules
12/21/2006	WO2006101441A3 Method for protein purification comprising heat incubation in acetic acidic solution
12/21/2006	WO2006097748A3 Peptide stabilizer compounds and screening method
12/21/2006	WO2006091773A3 Compositions and methods related to serpin spi6
12/21/2006	WO2006083887A3 Production of packaged dna sequences
12/21/2006	WO2006083289A3 Methods and compositions for enhancement of immunity by in vivo depletion of immunosuppressive cell activity
12/21/2006	WO2006081207A3 Process for genetic engineering of cell lines
12/21/2006	WO2006080032A3 Antifungal protein
12/21/2006	WO2006079790A3 Controlled production and delivery of biologically active agents by gut bacteria
12/21/2006	WO2006078271A3 Cloning and expression of the full length 110 kda antigen of orientia tsutsugamushi to be used as a vaccine component against scrub typhus
12/21/2006	WO2006076288A3 Dna constructs for long-term expression of intravascularly injected naked dna
12/21/2006	WO2006073827A3 Neutralizing epitope-based growth enhancing vaccine
12/21/2006	WO2006072593A3 Device for magnet assisted transfer of chemical compounds into cells and method for magnet assisted transfer of proteins into cells
12/21/2006	WO2006064519A3 Dnazymes for inhibition of japanese encephalitis virus replication
12/21/2006	WO2006059130A3 Manipulation of starch granule size and number (ii)
12/21/2006	WO2006053871A3 Multivalent vaccines comprising recombinant viral vectors
12/21/2006	WO2006042112A3 Aptamer regulated nucleic acids and uses thereof
12/21/2006	WO2006041897A3 Chimeric vectors
12/21/2006	WO2005121172A8 Peptide capable of altering tubulin polymerization and use thereof for inhibiting cell proliferation
12/21/2006	WO2005104810A3 Novel therapeutic targets in cancer
12/21/2006	WO2005099449A3 Animal model, cells, and treatment for malignant melanoma
12/21/2006	WO2005086835A3 Aptamers to the human il-12 cytokine family and their use as autoimmune disease therapeutics
12/21/2006	WO2005086794A3 Lactobacillus acidophilus nucleic acid sequences encoding stress-related proteins and uses therefor
12/21/2006	WO2005040339A3 Aptamers to human epidermal growth factor receptor-3
12/21/2006	WO2005027711A3 Capsid-modified adenovirus vectors and methods of using the same
12/21/2006	WO2004078922A3 Modulation of growth hormone receptor expression and insulin-like growth factor expression

1 ... 1687 1688 1689 1690 1691 1692 1693 1694 1695 1696 1697 1698 1699 1700 1701 1702 1703 1704 1705 1706 1707 ... 4023